1-15 of 86
Hypoparathyroidism – The Critical Role of Genetics in Your Differential Diagnosis
CME/CEHypoparathyroidism – The Critical Role of Genetics in Your Differential Diagnosis
Dolores Shoback, MD
Michael T. Collins, MD
Conference Coverage at ICCBH 2026: From Achondroplasia Presentation to Practice
CME/CEConference Coverage at ICCBH 2026: From Achondroplasia Presentation to Practice
Ravi Savarirayan, MBBS, MD
Julie Hoover-Fong, MD, PhD, FACMGG
Michael A. Levine, MD, ML, MACE
Aliya Khan, MD, FRCPC, FACP, FACE, FASBMR
Optimizing Body Composition Changes in the Era of Incretin-Based Weight Loss Therapies
CME/CEOptimizing Body Composition Changes in the Era of Incretin-Based Weight Loss Therapies
Augusto Enrique Caballero-Robles, MD
Carla Prado, PhD, RD, FCAHS
Lars Johansson, PhD
Donna H. Ryan, MD
Stefan D. Anker, MD, PhD
Prem S. Subramanian, MD, PhD
Kimberly Cockerham, MD
Prem S. Subramanian, MD, PhD
Andrea Lora Kossler, MD, FACS
- advertisement
Overcoming Real-World Barriers to TED Treatment
MinuteCE®Overcoming Real-World Barriers to TED Treatment
Prem S. Subramanian, MD, PhD
Andrea Lora Kossler, MD, FACS
Prem S. Subramanian, MD, PhD
Andrea Lora Kossler, MD, FACS
Kimberly Cockerham, MD
Beyond IGF-1R: IL-6R Inhibition and Future Sequencing
MinuteCE®Beyond IGF-1R: IL-6R Inhibition and Future Sequencing
Prem S. Subramanian, MD, PhD
Kimberly Cockerham, MD
Why Staging TED Correctly Matters Even When CAS Is Low
MinuteCE®Why Staging TED Correctly Matters Even When CAS Is Low
Andrea Lora Kossler, MD, FACS
Kimberly Cockerham, MD
Comparing Trial Designs & Outcomes Across IGF-1R Therapies
MinuteCE®Comparing Trial Designs & Outcomes Across IGF-1R Therapies
Andrea Lora Kossler, MD, FACS
Kimberly Cockerham, MD
Designing Efficient Clinic Workflows for TED Therapy Access
MinuteCE®Designing Efficient Clinic Workflows for TED Therapy Access
Prem S. Subramanian, MD, PhD
Kimberly Cockerham, MD
- advertisement
Understanding IGF-1R Inhibition: Mechanism & Clinical Implications
MinuteCE®Understanding IGF-1R Inhibition: Mechanism & Clinical Implications
Prem S. Subramanian, MD, PhD
Andrea Lora Kossler, MD, FACS
From Prevalence to Practice: Practical Screening and Workup for Hypercortisolism in Resistant Hypertension
CME/CEFrom Prevalence to Practice: Practical Screening and Workup for Hypercortisolism in Resistant Hypertension
Jorge Plutzky, MD
Bradley Eilerman, MD, MHI
Encaleret in Autosomal Dominant Hypocalcemia Type 1: Clinical Implications From the Phase 3 CALIBRATE Trial
EndocrinologyEncaleret in Autosomal Dominant Hypocalcemia Type 1: Clinical Implications From the Phase 3 CALIBRATE Trial
Michael A. Levine, MD, ML, MACE
